MedPath

Evaluation of the Avaulta Procedure for the Correction of Pelvic Organ Prolapse - Results at 1 Year

Completed
Conditions
Pelvic Organ Prolapse
Registration Number
NCT00774215
Lead Sponsor
Atlantic Health System
Brief Summary

This study is a 1 year review of all patients who had surgery to correct pelvic organ prolapse (i.e. cystocele, rectocele, enterocele) using the Avaulta synthetic mesh kit.

Detailed Description

This is a retrospective cohort analysis of all patients who experienced vaginal prolapse and were operated on with the Avaulta synthetic vaginal mesh "kit" from January 2006 to April 2007. The Avaulta synthetic mesh is composed of polypropylene which is a monofilament. The objective of this trial is to compare patients objectively and subjectively at least one year after placement of the Avaulta synthetic vaginal mesh in terms of prolapse symptoms.

This data will be compared to pre-operative data already collected for these patients as a part of their routine surgical work-up. Mesh-related complications will be quantified, including erosions, new-onset pain, and infections. Success and anatomic recurrence rates will be recorded as well

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
103
Inclusion Criteria
  • All patiAll patients who underwent surgery with the Avaulta synthetic mesh kit from 1/06 - 4/08.
Exclusion Criteria
  • Unable to give informed consent to participate

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Anatomical success rates 1 year after surgery to correct pelvic organ prolapse with the Avaulta synthetic mesh kit1 year post operatively
Secondary Outcome Measures
NameTimeMethod
Mesh complications 1 year after surgery with the Avaulta synthetic mesh kit1 year

Trial Locations

Locations (1)

Atlantic Health System - Division of Urogynecology

🇺🇸

Morristown, New Jersey, United States

© Copyright 2025. All Rights Reserved by MedPath